Immutep Limited is a biotechnology company developing immunotherapy treatments for cancer and autoimmune diseases, focusing on modulating the immune system to enhance patient outcomes.
Ticker code: IMM
Sector: Healthcare | Industry: Biotechnology | Website: https://www.immutep.com
Market Information
| Market Capitalisation | Enterprise Value | Shares Outstanding | Free Float [%] | Free Float Value |
|---|---|---|---|---|
| $375,339,680 | $253,577,024 | 1471920338.0 | 83.01 | $311,553,194 |
Balance Sheet & Quality
| Equity | Cash | Debt | Return On Equity (ROE) | EBITDA 25 Margin [%] | Net Debt / Equity [%] | Rule of 40 |
|---|---|---|---|---|---|---|
| $144,248,191 | $129,692,992 | $1,625,182 | None | None | -88.8 | None |
Technicals & Short Data
| 3EMA Status | Volatility [%] | Value Traded Today | Average Daily Liquidity | Short [%] | Days To Cover |
|---|---|---|---|---|---|
| Negative | 10.1 | $195,147 | $593,279 | None | 0.0 |
Dividends
| Previous Dividend | Last Dividend | Franking [%] | Ex-Div Date | Gross Yield [%] |
|---|---|---|---|---|
| None | None | None | None | None |
Price Performance Snapshot
| Last Traded Price | Change [%] | 1 Week [%] | 1 Month [%] | 3 Months [%] | 6 Months [%] | 12 Months [%] |
|---|---|---|---|---|---|---|
| $0.255 | -1.9 | -13.6 | 218.7 | 8.5 | -5.6 | -25.0 |
IMM Price Chart with Volume and 3EMA
IMM Short Positions
Click HERE to understand why the above moving averages have been chosen.